Cypher Coronary Stent Information

Recent studies have indicated that drug-eluting Cypher Stents have been found to raise the risk of fatal blood clots.

UPDATE: November 29, 2006--An analysis by the Cleveland Clinic Foundation, published in the American Journal of Medicine, found that blood clots are four to five times more likely to develop in patients with drug-coated stents, compared to the older, bare-metal versions.

The Cordis Corporation's Cypher Coronary Stents are used to treat clogged arteries in heart patients. The stents are metal-mesh tubes that prop open coronary arteries.

These drug-coated stents are intended to help prevent formation of scar tissue that can form new blockages after surgery, but studies have found that they carry very serious health risks.

Weitz & Luxenberg is no longer accepting Stent cases.

see also:

FDA Update 2006 FDA Update on Coronary Drug-Eluting Stents such as Cypher, Taxus
Be Aware of FDA Update on Adverse Events with Cordis Cypher Stents

FDA Advisory 2003 FDA Letter Warn Physicians of Adverse Effects with Cypher Stents
FDA: Adverse Effects have been associated with Cypher Stents

Permax Read about Permax (Pergolide), Dangerous Drug for Parkinson's disease
FREE Lawsuit Case Evaluation on Permax (Pergolide), recalled drug